@ISTAND

The U.S. Food and Drug Administration's Center for Drug Evaluation and Research accepted the first Letter of Intent for an in silico drug development tool into the Innovative Science and Technology Ap…

The U.S. Food and Drug Administration's Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program is expanding the types of drug development tools (DDTs) eligible for qualifica…